SEC Company Response from Unicycive Therapeutics, (UNCY) — Jun 11, 2026
Unicycive Therapeutics, Inc.
Date: June 11, 2026 · CIK: 0001766140 · Accession: 0001213900-26-067967
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296545
Letter
Unicycive Therapeutics, Inc.
1975 W. El Camino Real, Suite 204
Mountain View, CA 94040
June 11, 2026
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance 100 F Street, N.E.
Washington, D.C. 20549
Attention: Tyler Howes
Re: Unicycive Therapeutics, Inc. Registration Statement on Form S-3
Filed June 5, 2026
File No. 333-296545
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), Unicycive Therapeutics, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Daylight Time, on Monday, June 15, 2026, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Please notify Greg Carney of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (213) 617-4209 as soon as possible as to the time the registration statement has been declared effective pursuant to this acceleration request.
Very truly yours,
UNICYCIVE THERAPEUTICS, INC.
Show Raw Text
CORRESP 1 filename1.htm Unicycive Therapeutics, Inc. 1975 W. El Camino Real, Suite 204 Mountain View, CA 94040 June 11, 2026 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tyler Howes Re: Unicycive Therapeutics, Inc. Registration Statement on Form S-3 Filed June 5, 2026 File No. 333-296545 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "Act"), Unicycive Therapeutics, Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 5:00 p.m., Eastern Daylight Time, on Monday, June 15, 2026, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. Please notify Greg Carney of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (213) 617-4209 as soon as possible as to the time the registration statement has been declared effective pursuant to this acceleration request. Very truly yours, UNICYCIVE THERAPEUTICS, INC. By: /s/ Shalabh Gupta Name: Shalabh Gupta Title: Chief Executive Officer cc: Greg Carney, Sheppard Mullin Richter & Hampton LLP